Advanced search
Publication Cover
Japanese Journal of Rheumatology Volume 7, 1997 - Issue 3
Journal homepage
4
Views
0
CrossRef citations to date
0
Altmetric
Case Report

A case of nasal T cell lymphoma with lethal midline granuloma which is clinically indistinguishable from Wegener’s granulomatosis

Toshihiro NankiFirst Department of Internal Medicine, Tokyo Medical and Dental University, 1-5-45, Yushima, Bunkyo-ku, Tokyo 113, Japan
,
Ryuji KoikeFirst Department of Internal Medicine, Tokyo Medical and Dental University, 1-5-45, Yushima, Bunkyo-ku, Tokyo 113, Japan
,
Noboru MizushimaFirst Department of Internal Medicine, Tokyo Medical and Dental University, 1-5-45, Yushima, Bunkyo-ku, Tokyo 113, Japan
,
Hitoshi KohsakaDivision of Immunological Diseases, Medical Research Institute, School of Medicine, Tokyo Medical and Dental University, 1-5-45, Yushima, Bunkyo-ku, Tokyo 113, Japan
,
Tetsuo KubotaFirst Department of Internal Medicine, Tokyo Medical and Dental University, 1-5-45, Yushima, Bunkyo-ku, Tokyo 113, Japan
&
Nobuyuki MiyasakaFirst Department of Internal Medicine, Tokyo Medical and Dental University, 1-5-45, Yushima, Bunkyo-ku, Tokyo 113, Japan
Pages 183-188 | Received 03 Jul 1996, Accepted 12 Dec 1996, Published online: 02 Jan 2014

REFERENCES

  • Burston H: Lethal midline granuloma: is it a pathologic entity? Laryngoscope 69: 1–43, 1959.
  • Tsokos M, Fauci AS, Costa J: Idiopathic midline destructive disease (IMDD): a subgroup of patients with the ‘midline granuloma’ syndrome. Am J Clin Pathol 77: 162–168, 1982.
  • Robinson AC, Fraser I, Bailey D et al.: Idiopathic midline destructive disease — case report and review of the literature. Postgrad Med J 60: 471–473, 1984.
  • Hirota J, Osaki T, Yoneda K et al.: Midline malignant B-cell lymphoma with leukemic transformation. Cancer 70: 2958–2962, 1992.
  • Leavitt RY, Fauci AS, Bloch DA et al.: The American College of Rheumatology 1990 criteria for the classification of Wegener’s granulomatosis. Arthritis Rheum 33: 1101–1107, 1990.
  • Harabuchi Y, Yamanaka N, Kataura A et ai: Epstein-Barr virus in nasal T-cell lymphomas in patients with lethal midline granuloma. Lancet 335: 128–130, 1990.
  • Kanavaros P, Lescs MC, Briere J et al.: Nasal T-cell lymphoma: a clinicopathologic entity associated with peculiar phenotype and with Epstein-Barr virus. Blood 81: 2688–2695, 1993.
  • Borisch B, Hennig I, Laeng RH et al.: Association of the subtype 2 of the Epstein-Barr virus with T-cell non-Hodgkin’s lymphoma of the midline granuloma type. Blood 82: 858–864, 1993.
  • Mishima K, Horiuchi K, Kojya S et al: Epstein-Barr virus in patients with polymorphic reticulosis (lethal midline granuloma) from China and Japan. Cancer 73: 3041–3046, 1994.
  • Aozasa K, Ohsawa M, Tornita Y et al: Polymorphic reticulosis is a neoplasm of large granular lymphocytes with CD3+ phenotype. Cancer 75: 894–901, 1995.
  • Prokocimer M, Modan M, Rusoshansky S et al: ProMACE-CytaBOM: combination chemotherapy for diffuse large cell lymphoma. Anticancer Res 9: 1233–1235, 1989.
  • Pavlovsky S, Corrado C, Santarelli MT et al: An update of two randomized trials in previously untreated multiple myeloma comparing melphalan and prednisone versus three- and five-drug combinations: an Argentine Group for Treatment of Acute Leukemia Study. J Clin Oncol 6: 769–775, 1988.
  • Fauci AS, Haynes BF, Katz P et al: Wegener’s granulomatosis: prospective clinical and therapeutic experience with 85 patients for 21 years. Ann Intern Med 98: 76–85, 1983.
  • Wiik A: Antineutrophil cytoplasmic antibodies in Wegener’s granulomatosis. Clin Exp Rheumatol 11: 191–201, 1993.
  • Hausen HZ, Schulte HH, Klein G et al: EBV DNA in biopsies of Burkitt tumours and anaplastic carcinomas of the nasopharynx. Nature 228: 1056–1058, 1970.
  • Cabane J, Raphael M, Lamas G et al: Origin of malignant centrofacial granulomas: surface markers and gene rearrangement of malignant cells. Laryngoscope 101: 998–1001, 1991.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.